Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.19 SEK | -0.94% | +13.50% | -22.61% |
23/02 | Abliva AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
2023 | Abliva AB Reaches Patient Enrollment Goal for Wave 1 of the FALCON Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.61% | 22M | |
+3.33% | 108B | |
+10.69% | 104B | |
+1.28% | 22.33B | |
-12.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.84% | 17.64B | |
+4.88% | 14.05B | |
+34.51% | 12.51B |
- Stock Market
- Equities
- ABLI Stock
- News Abliva AB
- Abliva Up 15% on US FDA's Orphan Designation for Mitochondrial Disease Treatment Candidate